Research study Program year 2025 Source: CMS Open Payments

Empa-Kidney

Research payments

$15,064,127

2,005 payments

Through program year 2025, $15,064,127 in research payments was reported against Empa-Kidney, across 2,005 payments.

Paid by (largest first)
Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharma GmbH & Co.KG
ClinicalTrials.gov
No trial number was reported for this study

By program year

5 rows
Year Kind Amount Payments
2025 Research $12,070 4
2024 Research $351,270 35
2021 Research $6,040,880 865
2020 Research $6,340,149 732
2019 Research $2,319,758 369

Breakdown

Who paid Research payments · program years 2019–2025
  1. Boehringer Ingelheim International GmbH $7,893,698 1,499 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $7,170,429 506 payments
Who received the money Research payments · program years 2019–2025
  1. Texas Institute For Kidney And Endocrine Disorders Organisation paid for research $587,411 65 payments
  2. Clinical Advancement Center Pllc Organisation paid for research $579,728 42 payments
  3. Nephrology Consultants Organisation paid for research $535,897 41 payments
  4. Total Research Group LLC Organisation paid for research $535,450 43 payments
  5. Seacoast Kidney And Hypertension Specialists Organisation paid for research $497,656 47 payments
  6. Northwestern University Organisation paid for research $445,555 46 payments
  7. Carolina Diabetes And Kidney Center LLC Organisation paid for research $425,577 48 payments
  8. Regional Health Clinical Research Organisation paid for research $422,501 40 payments
  9. Yale University School Of Medicine Organisation paid for research $415,377 47 payments
  10. Providence Medical Research Center Organisation paid for research $410,503 46 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record